Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections

To Compare the Efficacy of Topical Vigamox Eye Drops at Tid 3 Days Prior to Intravitreal Injection Versus Tid 1 Day Prior to Intravitreal Injection

NCT00690313•Illinois Retina Associates

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Intravitreal Injection Patients

Interventions

Vigamox

Locations

United States

Locations (1)

Illinois Retina Associates

Harvey, Illinois, United States

Key Dates

Start Date

August 1, 2008

Primary Completion Date

April 1, 2011

Completion Date

April 1, 2011

Last Updated

August 7, 2019

Sponsors

Lead Sponsor

Illinois Retina Associates

Collaborators

Alcon Research

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 7, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions